Drugs / Aza
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05577611 Background | Aug 2022 → Dec 2024 | acute myeloid leukemia | Zhongnan Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aza | “Aza 100mg, 75mg/m2/d, IVGTT, D-10 to D-4” NCT05577611 ↗ |